Literature DB >> 30386916

Increasing mixed venous oxygen saturation is a predictor of improved renal function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Sarasa Isobe1, Yuji Itabashi2, Takashi Kawakami1, Masaharu Kataoka1, Shun Kohsaka1, Toshimitsu Tsugu1, Mai Kimura1, Mitsuaki Sawano1, Toshiomi Katsuki1, Takashi Kohno1, Jin Endo1, Mitsushige Murata3, Keiichi Fukuda1.   

Abstract

Balloon pulmonary angioplasty (BPA) has emerged as an effective treatment for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Renal function has been identified as a prognostic marker in patients with pulmonary hypertension in previous studies. We, therefore, aimed to investigate the clinical parameters associated with improvements in renal function in patients with CTEPH. A total of 45 consecutive patients with inoperable CTEPH undergoing BPA (mean age 62.2 ± 15.1 years) were included in the study. We evaluated the patients' clinical characteristics at baseline and at 1-year post-BPA, and investigated the association between renal function and hemodynamic parameters, including right heart function. Hemodynamics and renal function showed sustained improvements at 1 year after BPA in 64.4% of patients. Improved estimated glomerular filtration rate (eGFR) was significantly correlated with increased cardiac index (r = 0.433, p = 0.003) and mixed venous oxygen saturation (SvO2; r = 0.459, p = 0.002), and with decreased mean pulmonary arterial pressure (r = - 0.420, p = 0.004) and pulmonary vascular resistance (r = -- 0.465, p = 0.001). Multivariate analysis revealed that an increase in SvO2 immediately after the final BPA was associated with improved eGFR after the 1st year (odds ratio 1.041; 95% confidence interval 1.004-1.078; P = 0.027). The cut-off value for predicting improved eGFR was an increase in SvO2 after the final BPA of >125.4% over the baseline value (specificity 100%, sensitivity 24.1%). In conclusion, BPA improved symptoms, right heart function, hemodynamics, and renal function up to the chronic phase. Increasing SvO2 by >125.4% above baseline in the acute phase is important for improving renal function at 1 year after BPA in CTEPH patients.

Entities:  

Keywords:  Balloon pulmonary angioplasty; Cardiac index; Chronic thromboembolic pulmonary hypertension; Mixed venous oxygen saturation; Renal function

Mesh:

Substances:

Year:  2018        PMID: 30386916     DOI: 10.1007/s00380-018-1284-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  21 in total

1.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  Gregory Piazza; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2011-01-27       Impact factor: 91.245

3.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

4.  Changes in Right Ventricular Dysfunction After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Toshimitsu Tsugu; Mitsushige Murata; Takashi Kawakami; Yugo Minakata; Hideaki Kanazawa; Masaharu Kataoka; Jin Endoh; Hikaru Tsuruta; Yuji Itabashi; Yuichiro Maekawa; Takayuki Abe; Keiichi Fukuda
Journal:  Am J Cardiol       Date:  2016-07-18       Impact factor: 2.778

5.  Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension.

Authors:  Yu Taniguchi; Kazuya Miyagawa; Kazuhiko Nakayama; Hiroto Kinutani; Toshiro Shinke; Kenji Okada; Yutaka Okita; Ken-ich Hirata; Noriaki Emoto
Journal:  EuroIntervention       Date:  2014-08       Impact factor: 6.534

6.  Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty.

Authors:  Takashi Kawakami; Aiko Ogawa; Katsumasa Miyaji; Hiroki Mizoguchi; Hiroto Shimokawahara; Takanori Naito; Takashi Oka; Kei Yunoki; Mitsuru Munemasa; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

7.  Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Masaharu Kataoka; Takumi Inami; Kentaro Hayashida; Nobuhiko Shimura; Haruhisa Ishiguro; Takayuki Abe; Yuichi Tamura; Motomi Ando; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Circ Cardiovasc Interv       Date:  2012-11-06       Impact factor: 6.546

8.  Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Authors:  Marion Delcroix; Irene Lang; Joanna Pepke-Zaba; Pavel Jansa; Andrea M D'Armini; Repke Snijder; Paul Bresser; Adam Torbicki; Sören Mellemkjaer; Jerzy Lewczuk; Iveta Simkova; Joan A Barberà; Marc de Perrot; Marius M Hoeper; Sean Gaine; Rudolf Speich; Miguel A Gomez-Sanchez; Gabor Kovacs; Xavier Jaïs; David Ambroz; Carmen Treacy; Marco Morsolini; David Jenkins; Jaroslav Lindner; Philippe Dartevelle; Eckhard Mayer; Gérald Simonneau
Journal:  Circulation       Date:  2016-01-29       Impact factor: 29.690

9.  Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.

Authors:  Akihisa Hanatani; Atsushi Shibata; Ryouko Kitada; Shinichi Iwata; Yoshiki Matsumura; Atsushi Doi; Kenichi Sugioka; Masahiko Takagi; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

View more
  5 in total

1.  Novel noninvasive estimation of mixed venous oxygen saturation by echocardiography and expired gas analysis.

Authors:  Takeshi Onoue; Mai Iwataki; Masaru Araki; Jun Akashi; Tetsuji Kitano; Yosuke Nabeshima; Soshi Hei; Yasufumi Nagata; Atsushi Hayashi; Yuki Tsuda; Shinjo Sonoda; Yoshihisa Fujino; Robert A Levine; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-18       Impact factor: 4.733

Review 2.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

3.  Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.

Authors:  Jun Nagata; Ayumi Sekine; Nobuhiro Tanabe; Yu Taniguchi; Keiichi Ishida; Yuki Shiko; Seiichiro Sakao; Koichiro Tatsumi; Takuji Suzuki
Journal:  BMC Pulm Med       Date:  2022-07-20       Impact factor: 3.320

4.  Different response of the oxygen pathway in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy versus balloon pulmonary angioplasty.

Authors:  Zhihui Fu; Xincao Tao; Wanmu Xie; Peiran Yang; Qian Gao; Jinzhi Wang; Zhenguo Zhai
Journal:  Front Cardiovasc Med       Date:  2022-09-27

Review 5.  Does kidney function matter in pulmonary thromboembolism management?

Authors:  Magdalena Pływaczewska; Piotr Pruszczyk; Maciej Kostrubiec
Journal:  Cardiol J       Date:  2021-01-20       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.